NUP98 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.243800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.116600E-01
Normal-vs-Stage2
9.975000E-01
Normal-vs-Stage3
2.717600E-01
Normal-vs-Stage4
4.740800E-01
Stage1-vs-Stage2
6.584200E-01
Stage1-vs-Stage3
1.417150E-01
Stage1-vs-Stage4
8.124200E-02
Stage2-vs-Stage3
1.122220E-01
Stage2-vs-Stage4
3.868600E-01
Stage3-vs-Stage4
3.011600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.268600E-01
Normal-vs-AfricanAmerican
8.754600E-01
Normal-vs-Asian
5.299800E-01
Caucasian-vs-AfricanAmerican
6.730200E-01
Caucasian-vs-Asian
2.785000E-01
AfricanAmerican-vs-Asian
3.140400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.999600E-01
Normal-vs-Female
8.235600E-01
Male-vs-Female
4.225000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.587200E-01
Normal-vs-Age(41-60Yrs)
6.583000E-01
Normal-vs-Age(61-80Yrs)
7.208600E-01
Normal-vs-Age(81-100Yrs)
8.840800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.714600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.316600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.503400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.018300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.551800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.528600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.893200E-01
Normal-vs-Daily Drinker
6.520800E-01
Normal-vs-Weekly Drinker
7.497600E-01
Normal-vs-Occasional Drinker
5.109800E-01
Normal-vs-Social Drinker
8.835200E-01
Non Drinker-vs-Daily Drinker
8.834000E-01
Non Drinker-vs-Weekly Drinker
9.213200E-01
Non Drinker-vs-Occasional Drinker
3.424400E-02
Non Drinker-vs-Social Drinker
2.926000E-01
Daily Drinker-vs-Weekly Drinker
8.325200E-01
Daily Drinker-vs-Occasional Drinker
3.591900E-02
Daily Drinker-vs-Social Drinker
2.685600E-01
Weekly Drinker-vs-Occasional Drinker
9.274000E-02
Weekly Drinker-vs-Social Drinker
4.229400E-01
Occasional Drinker-vs-Social Drinker
3.714000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.350200E-01
Normal-vs-Grade 2
5.989800E-01
Normal-vs-Grade 3
5.725200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.466100E-02
Grade 1-vs-Grade 3
3.494000E-02
Grade 1-vs-Grade 4
3.350200E-01
Grade 2-vs-Grade 3
4.565800E-01
Grade 2-vs-Grade 4
5.989800E-01
Grade 3-vs-Grade 4
5.725200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.760800E-01
Normal-vs-NonDiabetic
7.936400E-01
Diabetic-vs-NonDiabetic
7.940200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.089400E-01
Normal-vs-NoPancreatitis
8.112400E-01
Pancreatitis-vs-NoPancreatitis
2.555000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.558200E-01
Normal-vs-N1
9.211000E-01
N0-vs-N1
5.906400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.169600E-01
Normal-vs-TP53-NonMutant
5.814000E-01
TP53-Mutant-vs-TP53-NonMutant
2.170200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
